Kinney, Kaitlin R.
Kirse, Haley A.
Stewart, Nathanial E.
Ip, Edward H.
Saldana, Santiago
DeMaioNewton, Hannah E.
Kimber, Michiyah
Smith, Hilary R.
Douglas, Heather E.
Kiraly, Drew D.
Hanlon, Colleen A.
Addicott, Merideth A.
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (R01 AA027705, T32 AA007565, P50 AA026117)
Article History
Received: 31 January 2025
Accepted: 20 August 2025
First Online: 10 November 2025
Declarations
:
: The ethical approval for this study was given by the Advocate Health-Wake Forest University School of Medicine IRB (Protocol #00061760). The IRB continuing review for this protocol was approved on 4/8/2025 and will run through April of 2026. Interested and eligible individuals provided written informed consent to participate in the study. Written informed consent will be obtained from all future participants as well.
: The authors affirm that all individuals involved in this study have provided their informed consent for the publication of the data and associated research findings. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. All authors have read and approved the final manuscript.
: Dr. Colleen Hanlon has financial interest in BrainsWay Ltd. The remaining authors declare that they have no competing interests.